Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cold Spring Harbor Laboratory obtains United States patent.


Cold Spring Harbor Laboratory The Cold Spring Harbor Laboratory  (Cold Spring Harbor, NY) has patented proteins are identified from human breast tumor tumor: see neoplasm.  cell lines (MDA-MB-231, T-47D and T-47D/Met) that interact specifically with the substrate-trapping mutant (programming) mutant - Microsoft's term for a mutex which is generally used in user mode but can also be used in kernel mode. According to this terminology a mutex is only used in kernel mode.

["Microsoft Windows NT Workstation Resource Kit"].
 form of Density Enhanced Phosphatase-1 (DEP-1). These proteins include the functional component p120 catenin (p120.sup.ctn), the adaptor protein An adaptor protein is a protein which is accessory to main proteins in a signal transduction pathway. These proteins tend to lack any intrinsic enzymatic activity themselves but instead mediate specific protein-protein interactions that drive the formation of protein complexes.  Gab 1, and the HGF/SF receptor Met. The invention relates to isolated complexes comprising DEP-1 polypeptides in specific association with Met, Gab 1, or p120.sup.ctn, identified herein as DEP-1 substrate polypeptides. Screening assays for agents that alter DEP-1 interaction with DEP-1 substrate polypeptides are also disclosed, as are methods for altering biological signals in cells that are transduced via DEP-1 pathways. (US 7,205,121)
COPYRIGHT 2007 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:Apr 1, 2007
Words:119
Previous Article:Wellstat BioCatalysis obtains United States patent.
Next Article:Mannatech obtains United States patent.
Topics:



Related Articles
ALNYLAM LICENSES INTELLECTUAL PROPERTY FROM COLD SPRING HARBOR.
Alnylam licenses gene silencing technology from Cold Spring Harbor.
Alnylam licenses gene silencing technology from Cold Spring Harbor.
Orion obtains patent covering genome-wide biomarker discovery platform.
du Pont obtains United States patent.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles